載入錯誤
看來載入頁面時發生了錯誤.
重新載入
我們的團隊已收到通知，但若此問題持續，請透過
電郵支援widget工具
聯絡我們。
524494
-7.2%
500257
-3.5%
533573
-3.4%
HK
前往
登入
觀察名單
觀點
ProPicks AI
篩選器
數據瀏覽
圖表
已儲存工作
收起
GSK Pharmaceuticals
NSEI:GLAXO
印度 / 保健 / 製藥
貨幣
₹
加入觀察名單
綜觀
股息
財報
模型
財務狀況
比較
穩健度
圖表
10 年 DCF 收入退出價
股價
2,778.45
INR
公允價值
2,056.65
INR
Metrics
Range
Conclusion
Discount Rate
8.8% - 7.8%
8.3%
Terminal Revenue Multiple
8.7x - 9.7x
9.2x
Fair Value
₹1,917 - ₹2,206
₹2,057
Upside
-33.5% - -23.4%
-28.6%
4.9%
Revenue 10y CAGR
31.9%
10y Avg EBITDA Margin
6.4%
Unlevered FCF 10y CAGR
10-Year DCF Model: Revenue Exit
分享
儲存
股價
2,778.45
INR
公允價值
2,056.65
INR
看漲
-28.6%
Revenue and EBITDA
CapEx
Working Capital
D&A
Tax Rate
Discount Rate
Terminal Value
Select Revenue and EBITDA Forecast
(INR in millions)
Input Projections
Fiscal Years Ending
Mar-24
Mar-25
Mar-26
Mar-27
Mar-28
Mar-29
Mar-30
Mar-31
Mar-32
Mar-33
Mar-34
Revenue
34,537
37,569
41,354
45,529
48,944
50,657
51,670
52,703
53,757
54,832
55,929
% Growth
6.2%
8.8%
10.1%
10.1%
7.5%
3.5%
2.0%
2.0%
2.0%
2.0%
2.0%
EBITDA
8,805
11,354
12,696
14,262
15,821
16,374
16,702
17,036
17,377
17,724
18,079
% of Revenue
25.5%
30.2%
30.7%
31.3%
32.3%
32.3%
32.3%
32.3%
32.3%
32.3%
32.3%
支援算式
Calculation of Free Cash Flow
Discounting Periods
Discounting Factors
Calculation of Enterprise Value
Equity Waterfall
Historical Financials
Current Trading Multiples
Calculation of Free Cash Flow
Projected Unlevered Cash Flow
Mar-25
Mar-26
Mar-27
Mar-28
Mar-29
Mar-30
Mar-31
Mar-32
Mar-33
Mar-34
EBITDA
11,354
12,696
14,262
15,821
16,374
16,702
17,036
17,377
17,724
18,079
Other Income / (Exp)
0
0
0
0
0
0
0
0
0
0
D&A
(716)
(583)
(187)
(200)
(208)
(212)
(216)
(220)
(225)
(229)
EBIT
10,638
12,113
14,075
15,620
16,167
16,490
16,820
17,156
17,499
17,849
Pro forma Taxes
(3,298)
(3,755)
(4,363)
(4,842)
(5,012)
(5,112)
(5,214)
(5,318)
(5,425)
(5,533)
NOPAT
5,789
7,340
8,358
9,712
10,778
11,155
11,378
11,606
11,838
12,075
12,316
Capital Expenditures
(312)
(500)
(500)
(500)
(538)
(556)
(531)
(542)
(543)
(539)
(541)
NWC Investment
766
1,150
1,435
1,584
1,295
650
384
392
400
408
416
(+) D&A
415
716
583
187
200
208
212
216
220
225
229
Free Cash Flow
6,658
8,706
9,876
10,982
11,736
11,456
11,443
11,672
11,915
12,168
12,420
% Growth
13%
11%
7%
-2%
0%
2%
2%
2%
2%
版權所有。
使用條款
繁體中文
English (UK)
English (India)
English (Canada)
English (Australia)
English (South Africa)
English (Philippines)
Deutsch
Español (España)
Español (México)
Français
Italiano
Nederlands
Português (Portugal)
Polski
Português (Brasil)
Русский
Türkçe
Ελληνικά
Svenska
Suomi
日本語
한국어
简体中文
Bahasa Indonesia
Bahasa Melayu
ไทย
Tiếng Việt
हिंदी